Comparison of Tocilizumab and Convalescent Plasma Therapy for COVID-19: A Systematic Review: OAJBS Publishers

Comparison of Tocilizumab and Convalescent Plasma Therapy for COVID-19: A Systematic Review by Steffi Rose Mathew in Open Access Journal of Biomedical Science

Background: The current pandemic referred to as coronavirus disease 2019 (COVID-19), has identified the causative respiratory pathogen as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). High viral load leads to cytokine storm (CS) and other symptoms that leads to severity, mortality and infectivity of patients. Methods: A review of databases PubMed and Google Scholar was conducted from May 25 to June 16, 2020. After exclusion of systematic reviews, studies on other treatment strategies, meta-analysis and articles not related to COVID-19 treatment, 21 clinical studies on COVID-19 infection of tocilizumab (TCZ) and convalescent plasma (CP) were identified and included.
https://biomedscis.com/fulltext/comparison-of-tocilizumab-and-convalescent-plasma-therapy-for-covid-19-a-systematic-review.ID.000215.php

To Know More About Open Access Journal of Biomedical Science Please Visit: Biomedscis
Are Click On:  https://Biomedscis.Com/


Comments

Popular posts from this blog

Review on Analysis of Breast Tumor with Methods of Treatment: OAJBS Publishers

Facile Synthesis of Chitosan Nanoparticle with Different Features and Histopathological Ultrastructural Study on The Effect of Its Bio-complex with Bovine Serum Albumin: OAJBS Publishers

Assessment of Medication Errors in Emergency Ward at Nekemte Referral Hospital, West Ethiopia: OAJBS Publishers